483 Merck Sharp & Dohme Apr 2019

483 Merck Sharp & Dohme Apr 2019

Kelly Kerr FDA, Anastasia Offordile FDA, Anastasia Onuorah FDA$119.00 - Available Now

FDA investigators audited the Merck Sharp & Dohme - West Point, PA, United States facility and issued inspectional observations (via FDA 483) on 30 Apr 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Apr 2019
  • Location: West Point, United States
  • FEI: 2510592
Add To Cart